| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |